APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transthyretin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transthyretin Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchTransthyretin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Transthyretin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Transthyretin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transthyretin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transthyretin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Transthyretin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Prothena Corp Plc, Regeneron Pharmaceuticals Inc and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transthyretin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transthyretin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transthyretin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transthyretin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transthyretin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transthyretin Market by Company

Alnylam Pharmaceuticals Inc

Arcturus Therapeutics Inc

Ionis Pharmaceuticals Inc

Neurimmune Holding AG

Prothena Corp Plc

Regeneron Pharmaceuticals Inc

Pfizer Inc

Transthyretin Segment by Type

AG-10

Inotersen Sodium

EDE-1307

CRX-1008

ALN-TTRsc02

Others

Transthyretin Segment by Application

Alzheimer's Disease

Familial Amyloid Neuropathies

Cardomyopathy

Neuropathy

Others

Transthyretin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transthyretin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transthyretin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transthyretin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transthyretin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transthyretin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AG-10 Table 2. Major Company of Inotersen Sodium Table 3. Major Company of EDE-1307 Table 4. Major Company of CRX-1008 Table 5. Major Company of ALN-TTRsc02 Table 6. Major Company of Others Table 7. Global Transthyretin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Transthyretin Sales by Type (2021-2026) & (k units) Table 9. Global Transthyretin Sales Market Share in Volume by Type (2021-2026) Table 10. Global Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 11. Global Transthyretin Sales Market Share in Value by Type (2021-2026) Table 12. Global Transthyretin Price by Type (2021-2026) & (US$/unit) Table 13. Global Transthyretin Sales by Type (2027-2032) & (k units) Table 14. Global Transthyretin Sales Market Share in Volume by Type (2027-2032) Table 15. Global Transthyretin Sales by Type (2027-2032) & (US$ Million) Table 16. Global Transthyretin Sales Market Share in Value by Type (2027-2032) Table 17. Global Transthyretin Price by Type (2027-2032) & (US$/unit) Table 18. North America Transthyretin Sales by Type (2021-2026) & (k units) Table 19. North America Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Transthyretin Sales by Type (2021-2026) & (k units) Table 21. Europe Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Transthyretin Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Transthyretin Sales by Type (2021-2026) & (k units) Table 25. Latin America Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Transthyretin Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Transthyretin Sales by Type (2021-2026) & (US$ Million) Table 28. Transthyretin Industry Trends Table 29. Transthyretin Industry Drivers Table 30. Transthyretin Industry Opportunities and Challenges Table 31. Transthyretin Industry Restraints Table 32. Global Transthyretin Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Transthyretin Revenue Market Share by Company (2021-2026) Table 34. Global Transthyretin Sales by Company (2021-2026) & (k units) Table 35. Global Transthyretin Sales Share by Company (2021-2026) Table 36. Global Transthyretin Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Transthyretin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Transthyretin Major Company Production Sites and Headquarters Table 39. Global Transthyretin Company, Product Type & Application Table 40. Global Transthyretin Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Transthyretin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Transthyretin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Transthyretin Sales by Region (2021-2026) & (k units) Table 45. Global Transthyretin Sales Market Share in Volume by Region (2021-2026) Table 46. Global Transthyretin Sales by Region (2021-2026) & (US$ Million) Table 47. Global Transthyretin Sales Market Share in Value by Region (2021-2026) Table 48. Global Transthyretin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Transthyretin Sales by Region (2027-2032) & (k units) Table 50. Global Transthyretin Sales Market Share in Volume by Region (2027-2032) Table 51. Global Transthyretin Sales by Region (2027-2032) & (US$ Million) Table 52. Global Transthyretin Sales Market Share in Value by Region (2027-2032) Table 53. Global Transthyretin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Transthyretin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Transthyretin Sales by Application (2021-2026) & (k units) Table 56. Global Transthyretin Sales Market Share in Volume by Application (2021-2026) Table 57. Global Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 58. Global Transthyretin Sales Market Share in Value by Application (2021-2026) Table 59. Global Transthyretin Price by Application (2021-2026) & (US$/unit) Table 60. Global Transthyretin Sales by Application (2027-2032) & (k units) Table 61. Global Transthyretin Sales Market Share in Volume by Application (2027-2032) Table 62. Global Transthyretin Sales by Application (2027-2032) & (US$ Million) Table 63. Global Transthyretin Sales Market Share in Value by Application (2027-2032) Table 64. Global Transthyretin Price by Application (2027-2032) & (US$/unit) Table 65. North America Transthyretin Sales by Application (2021-2026) & (k units) Table 66. North America Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Transthyretin Sales by Application (2021-2026) & (k units) Table 68. Europe Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Transthyretin Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Transthyretin Sales by Application (2021-2026) & (k units) Table 72. Latin America Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Transthyretin Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Transthyretin Sales by Application (2021-2026) & (US$ Million) Table 75. Alnylam Pharmaceuticals Inc Company Information Table 76. Alnylam Pharmaceuticals Inc Business Overview Table 77. Alnylam Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio Table 79. Alnylam Pharmaceuticals Inc Recent Development Table 80. Arcturus Therapeutics Inc Company Information Table 81. Arcturus Therapeutics Inc Business Overview Table 82. Arcturus Therapeutics Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Arcturus Therapeutics Inc Transthyretin Product Portfolio Table 84. Arcturus Therapeutics Inc Recent Development Table 85. Ionis Pharmaceuticals Inc Company Information Table 86. Ionis Pharmaceuticals Inc Business Overview Table 87. Ionis Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Ionis Pharmaceuticals Inc Transthyretin Product Portfolio Table 89. Ionis Pharmaceuticals Inc Recent Development Table 90. Neurimmune Holding AG Company Information Table 91. Neurimmune Holding AG Business Overview Table 92. Neurimmune Holding AG Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Neurimmune Holding AG Transthyretin Product Portfolio Table 94. Neurimmune Holding AG Recent Development Table 95. Prothena Corp Plc Company Information Table 96. Prothena Corp Plc Business Overview Table 97. Prothena Corp Plc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Prothena Corp Plc Transthyretin Product Portfolio Table 99. Prothena Corp Plc Recent Development Table 100. Regeneron Pharmaceuticals Inc Company Information Table 101. Regeneron Pharmaceuticals Inc Business Overview Table 102. Regeneron Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio Table 104. Regeneron Pharmaceuticals Inc Recent Development Table 105. Pfizer Inc Company Information Table 106. Pfizer Inc Business Overview Table 107. Pfizer Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Pfizer Inc Transthyretin Product Portfolio Table 109. Pfizer Inc Recent Development Table 110. North America Transthyretin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 111. North America Transthyretin Sales by Country (2021-2026) & (k units) Table 112. North America Transthyretin Sales Market Share by Country (2021-2026) Table 113. North America Transthyretin Sales Forecast by Country (2027-2032) & (k units) Table 114. North America Transthyretin Sales Market Share Forecast by Country (2027-2032) Table 115. North America Transthyretin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Transthyretin Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Transthyretin Market Share by Country (2021-2026) Table 118. North America Transthyretin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Transthyretin Market Share Forecast by Country (2027-2032) Table 120. Europe Transthyretin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 121. Europe Transthyretin Sales by Country (2021-2026) & (k units) Table 122. Europe Transthyretin Sales Market Share by Country (2021-2026) Table 123. Europe Transthyretin Sales Forecast by Country (2027-2032) & (k units) Table 124. Europe Transthyretin Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Transthyretin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Transthyretin Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Transthyretin Market Share by Country (2021-2026) Table 128. Europe Transthyretin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Transthyretin Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Transthyretin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Transthyretin Sales by Country (2021-2026) & (k units) Table 132. Asia-Pacific Transthyretin Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Transthyretin Sales Forecast by Country (2027-2032) & (k units) Table 134. Asia-Pacific Transthyretin Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Transthyretin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Transthyretin Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Transthyretin Market Share by Country (2021-2026) Table 138. Asia-Pacific Transthyretin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Transthyretin Market Share Forecast by Country (2027-2032) Table 140. Latin America Transthyretin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. Latin America Transthyretin Sales by Country (2021-2026) & (k units) Table 142. Latin America Transthyretin Sales Market Share by Country (2021-2026) Table 143. Latin America Transthyretin Sales Forecast by Country (2027-2032) & (k units) Table 144. Latin America Transthyretin Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Transthyretin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Transthyretin Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Transthyretin Market Share by Country (2021-2026) Table 148. Latin America Transthyretin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Transthyretin Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Transthyretin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Transthyretin Sales by Country (2021-2026) & (k units) Table 152. Middle East and Africa Transthyretin Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Transthyretin Sales Forecast by Country (2027-2032) & (k units) Table 154. Middle East and Africa Transthyretin Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Transthyretin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Transthyretin Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Transthyretin Market Share by Country (2021-2026) Table 158. Middle East and Africa Transthyretin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Transthyretin Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Transthyretin Distributors List Table 163. Transthyretin Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Transthyretin Image Figure 2. Global Transthyretin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transthyretin Market Size (2021-2032) & (US$ Million) Figure 4. Global Transthyretin Sales (2021-2032) & (k units) Figure 5. AG-10 Image Figure 6. Global AG-10 Sales YoY Growth (2021-2032) & (k units) Figure 7. Inotersen Sodium Image Figure 8. Global Inotersen Sodium Sales YoY Growth (2021-2032) & (k units) Figure 9. EDE-1307 Image Figure 10. Global EDE-1307 Sales YoY Growth (2021-2032) & (k units) Figure 11. CRX-1008 Image Figure 12. Global CRX-1008 Sales YoY Growth (2021-2032) & (k units) Figure 13. ALN-TTRsc02 Image Figure 14. Global ALN-TTRsc02 Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Transthyretin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Transthyretin Market Share by Type 2025 VS 2032 Figure 19. North America Transthyretin Sales Market Share in Volume by Type in 2025 Figure 20. North America Transthyretin Sales Market Share in Value by Type in 2025 Figure 21. Europe Transthyretin Sales Market Share in Volume by Type in 2025 Figure 22. Europe Transthyretin Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Transthyretin Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Transthyretin Sales Market Share in Value by Type in 2025 Figure 25. Latin America Transthyretin Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Transthyretin Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Transthyretin Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Transthyretin Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Transthyretin Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Alzheimer's Disease Image Figure 32. Global Alzheimer's Disease Sales YoY Growth (2021-2032) & (k units) Figure 33. Familial Amyloid Neuropathies Image Figure 34. Global Familial Amyloid Neuropathies Sales YoY Growth (2021-2032) & (k units) Figure 35. Cardomyopathy Image Figure 36. Global Cardomyopathy Sales YoY Growth (2021-2032) & (k units) Figure 37. Neuropathy Image Figure 38. Global Neuropathy Sales YoY Growth (2021-2032) & (k units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 41. Global Transthyretin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Transthyretin Market Share by Application 2025 VS 2032 Figure 43. North America Transthyretin Sales Market Share in Volume by Application in 2025 Figure 44. North America Transthyretin Sales Market Share in Value by Application in 2025 Figure 45. Europe Transthyretin Sales Market Share in Volume by Application in 2025 Figure 46. Europe Transthyretin Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Transthyretin Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Transthyretin Sales Market Share in Value by Application in 2025 Figure 49. Latin America Transthyretin Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Transthyretin Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Transthyretin Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Transthyretin Sales Market Share in Value by Application in 2025 Figure 53. North America Transthyretin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America Transthyretin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Transthyretin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Transthyretin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Transthyretin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe Transthyretin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Transthyretin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Transthyretin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Transthyretin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific Transthyretin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Transthyretin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Transthyretin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Transthyretin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America Transthyretin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Transthyretin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Transthyretin Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Transthyretin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa Transthyretin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Transthyretin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Transthyretin Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Transthyretin Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Transthyretin Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • AG-10
  • Inotersen Sodium
  • EDE-1307
  • CRX-1008
  • ALN-TTRsc02
  • Others
Applications
  • Alzheimer's Disease
  • Familial Amyloid Neuropathies
  • Cardomyopathy
  • Neuropathy
  • Others
Companies covered
  • Alnylam Pharmaceuticals Inc
  • Arcturus Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • Neurimmune Holding AG
  • Prothena Corp Plc
  • Regeneron Pharmaceuticals Inc
  • Pfizer Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transthyretin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transthyretin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transthyretin Market by Type
  6. 1.3.1 AG-10
  7. 1.3.2 Inotersen Sodium
  8. 1.3.3 EDE-1307
  9. 1.3.4 CRX-1008
  10. 1.3.5 ALN-TTRsc02
  11. 1.3.6 Others
  12. 1.4 Global Transthyretin Market Size by Type
  13. 1.4.1 Global Transthyretin Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Transthyretin Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Transthyretin Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Transthyretin Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Transthyretin Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Transthyretin Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Transthyretin Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Transthyretin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transthyretin Industry Trends
  2. 2.2 Transthyretin Industry Drivers
  3. 2.3 Transthyretin Industry Opportunities and Challenges
  4. 2.4 Transthyretin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transthyretin Revenue (2021-2026)
  2. 3.2 Global Top Players by Transthyretin Sales (2021-2026)
  3. 3.3 Global Top Players by Transthyretin Price (2021-2026)
  4. 3.4 Global Transthyretin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transthyretin Major Company Production Sites & Headquarters
  6. 3.6 Global Transthyretin Company, Product Type & Application
  7. 3.7 Global Transthyretin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transthyretin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transthyretin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transthyretin Tier 1, Tier 2, and Tier 3
4 Transthyretin Regional Status and Outlook
  1. 4.1 Global Transthyretin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transthyretin Historic Market Size by Region
  3. 4.2.1 Global Transthyretin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transthyretin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transthyretin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transthyretin Forecasted Market Size by Region
  7. 4.3.1 Global Transthyretin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transthyretin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transthyretin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transthyretin by Application
  1. 5.1 Transthyretin Market by Application
  2. 5.1.1 Alzheimer's Disease
  3. 5.1.2 Familial Amyloid Neuropathies
  4. 5.1.3 Cardomyopathy
  5. 5.1.4 Neuropathy
  6. 5.1.5 Others
  7. 5.2 Global Transthyretin Market Size by Application
  8. 5.2.1 Global Transthyretin Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Transthyretin Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Transthyretin Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Transthyretin Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Transthyretin Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Transthyretin Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Transthyretin Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Transthyretin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alnylam Pharmaceuticals Inc
  2. 6.1.1 Alnylam Pharmaceuticals Inc Company Information
  3. 6.1.2 Alnylam Pharmaceuticals Inc Business Overview
  4. 6.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio
  6. 6.1.5 Alnylam Pharmaceuticals Inc Recent Developments
  7. 6.2 Arcturus Therapeutics Inc
  8. 6.2.1 Arcturus Therapeutics Inc Company Information
  9. 6.2.2 Arcturus Therapeutics Inc Business Overview
  10. 6.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio
  12. 6.2.5 Arcturus Therapeutics Inc Recent Developments
  13. 6.3 Ionis Pharmaceuticals Inc
  14. 6.3.1 Ionis Pharmaceuticals Inc Company Information
  15. 6.3.2 Ionis Pharmaceuticals Inc Business Overview
  16. 6.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio
  18. 6.3.5 Ionis Pharmaceuticals Inc Recent Developments
  19. 6.4 Neurimmune Holding AG
  20. 6.4.1 Neurimmune Holding AG Company Information
  21. 6.4.2 Neurimmune Holding AG Business Overview
  22. 6.4.3 Neurimmune Holding AG Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neurimmune Holding AG Transthyretin Product Portfolio
  24. 6.4.5 Neurimmune Holding AG Recent Developments
  25. 6.5 Prothena Corp Plc
  26. 6.5.1 Prothena Corp Plc Company Information
  27. 6.5.2 Prothena Corp Plc Business Overview
  28. 6.5.3 Prothena Corp Plc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Prothena Corp Plc Transthyretin Product Portfolio
  30. 6.5.5 Prothena Corp Plc Recent Developments
  31. 6.6 Regeneron Pharmaceuticals Inc
  32. 6.6.1 Regeneron Pharmaceuticals Inc Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Inc Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Inc Recent Developments
  37. 6.7 Pfizer Inc
  38. 6.7.1 Pfizer Inc Company Information
  39. 6.7.2 Pfizer Inc Business Overview
  40. 6.7.3 Pfizer Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc Transthyretin Product Portfolio
  42. 6.7.5 Pfizer Inc Recent Developments
7 North America by Country
  1. 7.1 North America Transthyretin Sales by Country
  2. 7.1.1 North America Transthyretin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transthyretin Sales by Country (2021-2026)
  4. 7.1.3 North America Transthyretin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transthyretin Market Size by Country
  6. 7.2.1 North America Transthyretin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transthyretin Market Size by Country (2021-2026)
  8. 7.2.3 North America Transthyretin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transthyretin Sales by Country
  2. 8.1.1 Europe Transthyretin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transthyretin Sales by Country (2021-2026)
  4. 8.1.3 Europe Transthyretin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transthyretin Market Size by Country
  6. 8.2.1 Europe Transthyretin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transthyretin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transthyretin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transthyretin Sales by Country
  2. 9.1.1 Asia-Pacific Transthyretin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transthyretin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transthyretin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transthyretin Market Size by Country
  6. 9.2.1 Asia-Pacific Transthyretin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transthyretin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transthyretin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transthyretin Sales by Country
  2. 10.1.1 South America Transthyretin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transthyretin Sales by Country (2021-2026)
  4. 10.1.3 South America Transthyretin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transthyretin Market Size by Country
  6. 10.2.1 South America Transthyretin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transthyretin Market Size by Country (2021-2026)
  8. 10.2.3 South America Transthyretin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transthyretin Sales by Country
  2. 11.1.1 Middle East and Africa Transthyretin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transthyretin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transthyretin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transthyretin Market Size by Country
  6. 11.2.1 Middle East and Africa Transthyretin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transthyretin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transthyretin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transthyretin Value Chain Analysis
  2. 12.1.1 Transthyretin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transthyretin Production Mode & Process
  7. 12.2 Transthyretin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transthyretin Distributors
  10. 12.2.3 Transthyretin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst